Skip to main content
. 2019 Aug 26;191(34):E932–E939. doi: 10.1503/cmaj.190274

Figure 1:

Figure 1:

Cost per quality-adjusted life-year (QALY) gained of vaccination with the recombinant subunit zoster vaccine (RZV) and the live attenuated zoster vaccine (LZV) compared with no vaccination, by age at vaccination and vaccine cost (complete series). Box plots represent the 5th, 25th, 50th, 75th and 95th percentiles from 30 000 simulation results. Costs are reported in 2018 Canadian dollars. CEA = cost-effectiveness analysis.